{"public_id":"cl_224024d88797c6f8bc7b4fe294369cc6","status":"active","superseded_by_public_id":null,"corpus_id":249828536,"text":"A relapsing course occurs in approximately 50% of patients.","confidence":0.94,"paper":{"corpus_id":249828536,"title":"Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management","url":"https://sah.borca.ai/papers/249828536"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.94,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_30ce035610156bd8441ef87bddb5ef37","name":"relapsing course","description":"A disease pattern in which attacks recur over time after initial presentation.","types":["disease course"],"url":"https://sah.borca.ai/concepts/co_30ce035610156bd8441ef87bddb5ef37"},{"public_id":"co_eba0ce7117ace30f35329b5395dbff5b","name":"MOGAD","description":"Myelin oligodendrocyte glycoprotein antibody-associated disease, an inflammatory demyelinating disorder of the central nervous system.","types":["disease"],"url":"https://sah.borca.ai/concepts/co_eba0ce7117ace30f35329b5395dbff5b"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_224024d88797c6f8bc7b4fe294369cc6"}